Goldman Sachs analyst Salveen Richter came out today with new ratings and price targets on a handful of biotechnology stocks. Lets take a look and see what Richter …
In a research report released Friday, Canaccord analyst John Newman reiterated a Buy rating on shares of Kite Pharma Inc (NASDAQ:KITE) with a price …
Kite Pharma Inc (NASDAQ:KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT™) products for the treatment of cancer, today …
Kite Pharma Inc (NASDAQ:KITE) announced upcoming presentations related to KTE-C19, Kite’s lead product candidate, that will take place at the 57th ASH Annual Meeting …
Kite Pharma Inc (NASDAQ:KITE) announced that it has entered into a worldwide research and license agreement with Alpine Immune Sciences, Inc. (AIS), a privately-held …
SanDisk Corporation (NASDAQ:SNDK) climbed 7.78% to $77.
Maxim’s healthcare analysts are weighing in on the Boston drug company Keryx Biopharmaceuticals (NASDAQ:KERX) and cancer drug discovery company Kite Pharma Inc (NASDAQ:KITE), following recent announcements. Keryx Biopharmaceuticals In a …
